StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

Analysts at StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Saturday. The brokerage set a “sell” rating on the medical technology company’s stock.

BIOLASE Price Performance

BIOL opened at $0.01 on Friday. The company has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01. The firm has a market cap of $360,795.60, a P/E ratio of 0.00 and a beta of 0.67. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.